AP214, an analogue of α-melanocyte-stimulating hormone, ameliorates sepsis-induced acute kidney injury and mortality
Open Access
- 1 June 2008
- journal article
- Published by Elsevier in Kidney International
- Vol. 73 (11) , 1266-1274
- https://doi.org/10.1038/ki.2008.97
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Cardiovascular and renal actions of melanocyte-stimulating hormone peptidesCurrent Opinion in Nephrology and Hypertension, 2007
- Simvastatin improves sepsis-induced mortality and acute kidney injury via renal vascular effectsKidney International, 2006
- α-MSH prevents impairment in renal function and dysregulation of AQPs and Na-K-ATPase in rats with bilateral ureteral obstructionAmerican Journal of Physiology-Renal Physiology, 2006
- In vivo delivery of caspase-8 or Fas siRNA improves the survival of septic miceBlood, 2005
- Dendrimer-enhanced MRI as a diagnostic and prognostic biomarker of sepsis-induced acute renal failure in aged miceKidney International, 2005
- α-Melanocyte-stimulating Hormone Protects from Ultraviolet Radiation-induced Apoptosis and DNA DamageJournal of Biological Chemistry, 2005
- Improved survival in experimental sepsis with an orally administered inhibitor of apoptosisThe FASEB Journal, 2004
- Ethyl pyruvate decreases sepsis-induced acute renal failure and multiple organ damage in aged miceKidney International, 2003
- The Pathophysiology and Treatment of SepsisNew England Journal of Medicine, 2003
- Prognostic factors in acute renal failure due to sepsis. Results of a prospective multicentre studyNephrology Dialysis Transplantation, 1996